The Effective Statistician - in association with PSI
Ever wondered about the intricate connections between observational studies and the Estimand framework in the pharmaceutical industry?
How do the challenges in multi-country primary data...
In today's episode, I embark on a personal and insightful journey with Mirjam Sandlos, not just a business coach but my personal guide in breaking mental chains.
Mirjam, a seasoned busin...
In this new episode, I and Guillaume Desachy delve into the world of R and its impact on the pharmaceutical industry. Guillaume, a Statistical Science Director at AstraZeneca in Sweden, shares h...
In the ever-evolving landscape of professional development, I've noticed that the term "strategy" is frequently thrown around, often without a clear understanding of its true meaning. Unfortunat...
This time, I'm engaging in a conversation with Katharina, and I must say I'm thrilled to explore more on the topic of ethical statistics. In our previous discussion, we delved into the importanc...
This is an extraordinary episode that takes us deep into the world of modern pharmaceutical research.
Today, we are embarking on a captivating journey guided by the insightful dialogue b...
I'm thrilled to dive into a topic that has been untouched in the past 300 episodes - crossover studies. It's a classical design that offers unique advantages, yet it's often overlooked.
...
In the intricate world of statistics organizations, a common challenge often arises: how to balance increasing cost pressures while maintaining the quality and relevance of the produced tables. ...